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Abstract
Sex hormones modulate the action of both cytokines and the renin-angiotensin system. However, the effects of angiotensin I-
converting enzyme (ACE) on the proinflammatory and anti-inflammatory cytokine levels in male and female spontaneously
hypertensive rats (SHR) are unclear. We determined the relationship between ACE activity, cytokine levels and sex differences
in SHR. Female (F) and male (M) SHR were divided into 4 experimental groups each (n = 7): sham + vehicle (SV), sham +
enalapril (10 mg/kg body weight by gavage), castrated + vehicle, and castrated + enalapril. Treatment began 21 days after
castration and continued for 30 days. Serum cytokine levels (ELISA) and ACE activity (fluorimetry) were measured. Male rats
exhibited a higher serum ACE activity than female rats. Castration reduced serum ACE in males but did not affect it in females.
Enalapril reduced serum ACE in all groups. IL-10 (FSV = 16.4 ± 1.1 pg/mL; MSV = 12.8 ± 1.2 pg/mL), TNF-a (FSV = 16.6
± 1.2 pg/mL; MSV = 12.8 ± 1 pg/mL) and IL-6 (FSV = 10.3 ± 0.2 pg/mL; MSV = 7.2 ± 0.2 pg/mL) levels were higher in
females than in males. Ovariectomy reduced all cytokine levels and orchiectomy reduced IL-6 but increased IL-10
concentrations in males. Castration eliminated the differences in all inflammatory cytokine levels (IL-6 and TNF-a) between
males and females. Enalapril increased IL-10 in all groups and reduced IL-6 in SV rats. In conclusion, serum ACE inhibition by
enalapril eliminated the sexual dimorphisms of cytokine levels in SV animals, which suggests that enalapril exerts systemic
anti-inflammatory and anti-hypertensive effects.
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Introduction
Angiotensin II (Ang II) is directly involved in various
biological functions including cell growth and proliferation,
mediation of oxidative stress (1), and key events
associated with the inflammatory process (2,3). Ang II
increases vascular permeability, recruits inflammatory
cells into tissues, and directly activates infiltrating immu-
nocompetent cells (3). Ang II also acts as a potent
proinflammatory mediator, promoting the generation of
cytokines and free radicals (2). Furthermore, sex hor-
mones modulate the action of cytokines (4) and the renin-
angiotensin system (RAS) (5).
Previous studies have demonstrated that differences
in autoimmune disease susceptibility between sexes may
be due to differences in cytokine production after
autoantigen-specific stimulation (6). Estrogens have been
shown to inhibit mRNA expression levels of platelet-
derived growth factor-A, IL-1, and IL-6 mRNA in human
vascular smooth muscle cells, a finding that suggests the
anti-inflammatory effects of estrogens (7). Similarly, in
vitro evidence has shown that testosterone may influence
the expression of proinflammatory and anti-inflammatory
cytokines (8-10). Differences between males and females
have been found in components of the RAS, such as
differences in the concentrations of prorenin, Ang II, and
angiotensinogen in humans (11) and animals (12,13). In
the hypertensive rat model (mRen(2).Lewis rat), angio-
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tensin I-converting enzyme (ACE) activity was higher in
males than in females (12), and sexual dimorphisms in
prorenin levels have been observed in humans (prorenin
levels in men were significantly higher than in women)
(11).
The pleiotropic anti-inflammatory effects of the ACE
inhibitors have been well established (13,14). However,
the effects of ACE on proinflammatory and anti-inflam-
matory cytokine levels in male and female SHR are not
clear. Therefore, the present study was designed to
investigate: 1) if there are sex differences in inflammatory
biomarkers (IL-10, IL-6, TNF-a) in spontaneous hyperten-
sion, 2) if sex hormones play a role in these sex
differences, and 3) if an ACE inhibitor enalapril interferes
with inflammatory biomarkers in male and female SHR.
Material and Methods
Animals
The study was conducted on 12-week-old male and
female SHR that initially weighed 150 ± 5 g (females)
and 230 ± 5 g (males) and that had free access to food
and water. The rats’ body weight was monitored during
the experiments. The animals were housed in standard
plastic cages at a constant temperature of 22 ˚C and on a
12-h light-dark cycle.
The procedures were carried out in compliance with
the guidelines for the ethical use of animals in scientific
research and were approved by the Ethics Committee of
Universidade Federal do Espı´rito Santo (#023/2009). All
surgical procedures were carried out under ketamine
(70 mg/kg, ip) and xylazine (10 mg/kg, ip) anesthesia.
Experimental design
Castration. Female rats were subjected to a skin
incision of 1 to 1.5 cm and a muscular incision to open the
peritoneal cavity for the connection of the uterine tubules
and ovary removal. The peritoneal cavity was then
cleaned and sutured. The estrous cycle of the sham rats
was monitored continuously with vaginal smears. This
group was subjected to the experimental protocol on the
day of proestrus. Orchiectomy was performed through an
anterior median incision in the scrotum and each testicle
was exposed through the surgical incision. The ductus
deferens was isolated, ligated, and severed, allowing the
testicle to be removed. The incision was then closed and
sutured with 3-0 chromic catgut.
The rats were divided into 4 experimental groups (n =
7) of female and male rats as follows: sham-operated
vehicle (SV), sham-operated treated with enalapril (SE),
castrated + vehicle (CV), and castrated and treated with
enalapril (CE). The treatments were started 21 days after
castration and continued for 30 days. Enalapril maleate
(Sigma, USA) was dissolved in water, and 10 mg
enalapril/kg body weight was administered daily by
gavage. A dose of 10 mg?kg-1?day-1 has been shown to
reduce blood pressure in male SHR of this age (15). The
rats’ systolic blood pressure (SBP) was measured at the
onset of the experiment and after 7 weeks of the
experimental period (21 days after castration and after
28 days of treatment).
Blood pressure determination
The SBP of conscious rats was measured using a tail-
cuff manometer manufactured by IITC Life Science Inc.
(USA). The animals were placed inside a warming
chamber (about 34 ˚C) for 30 min before the measure-
ments. The aim of the procedure was to calm the animals
and dilate the blood vessels in the tail. The arterial blood
pressure of each animal was measured at least three
times. Any changes in pressure were reported as baseline
value variation.
Determining estrous cycle phase
Daily vaginal smears were taken from each female rat
as previously described (16) to confirm that their estrous
cycles were proceeding normally. The vaginal epithelial
cells were examined by microscopy for at least 7
consecutive days before the experiment. The swabs were
performed between 8:00 and 10:00 am to maintain
consistency. The females exhibiting normal estrous cycles
were killed at proestrus between 9:00 am and 1:00 pm.
Measurement of cytokine levels, ACE activity and
hormone levels. After measuring the SBP, the rats were
decapitated without anesthesia, and 8 mL blood was
collected into empty tubes to obtain serum (4 mL) for the
determination of cytokines and plasma (4 mL) for the
determination of ACE activity. The blood samples were
centrifuged at 4 ˚C and 1000 g (Eppendorf, Germany) for
15 min. Serum and plasma were stored at -80 ˚C. IL-6, IL-
10, and TNF-a levels were measured by ELISA according
to manufacturer specifications (Biosource International,
USA). The experiments were performed in duplicate.
The proteolytic activity assay that was used to deter-
mine ACE activity in plasma utilized Abz-FRK(Dnp)P-OH
(Aminotech Pesquisa e Desenvolvimento, Brazil) as a
substrate, which is ideal for studies of enzyme kinetics
and the analysis of the somatic activity of the C- and N-
terminal domains of ACE. The assay methodology was
adapted to a fluorescence plate reader with a 96-well
format and utilized excitation at 320 nm and emission at
420 nm. ACE activity is reported in arbitrary fluorescence
units (AFU) (17).
Testosterone and estradiol concentrations were deter-
mined by ELISA. Testosterone (10 mL serum sample;
AccuBindTM, Monobind Inc., USA; sensitivity of 0.038 ng/
mL) and estradiol (25 mL serum sample; AccuBindTM,
Monobind Inc.; sensitivity of 0.0065 ng/mL) were mea-
sured in duplicate. The uterus was removed and weighed.
Statistical analysis
Data are reported as means ± SE. Statistical analysis
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was performed by repeated measures two-way ANOVA
followed by the Fisher least significant differences post
hoc comparison for all statistical analyses. A P value
,0.05 was considered to be statistically significant. The
statistical analyses were performed with the GB Stat
software (USA).
Results
Blood pressure and body weight
Table 1 shows the SBP of all of the groups studied.
The initial SBP of the male (M) groups (MSV, MCV, MSE,
and MCE) was higher than that of the female (F) groups
(FSV, FCV, FSE, and FCE). After the experimental
period, the SBP of male rats (MSV and MCV) continued
to be higher than the SBP of female rats (FSV, FCV).
Castration did not alter the blood pressure of either sex.
As expected, treatment with enalapril reduced the SBP in
both the non-castrated (MSE and FSE) and the castrated
(MCE and FCE) groups, resulting in similar blood
pressure levels in all of these groups. However, the
observed percent decline was greater in males (SE =
-30%, CE = -33%, P , 0.05) than in females (SE =
-19%, CE = -25%).
The initial and final body weights (BW) of the male
groups (MSV, MCV, MSE, MCE) were different from
those of the respective female groups (FSV, FCV, FSE,
FCE). All groups had an increase in their final BW after
the experimental period. No differences were detected in
the initial weight of the female groups; however, after the
experimental period, the ovariectomized females (FCV
and FCE) exhibited an increase in final BW compared to
the sham females (FSV and FSE; Table 1).
ACE activity
Male rats exhibited higher ACE activity than female
rats (MSV = 1500 ± 131 AFU; FSV = 1234 ± 80 AFU).
In comparison with the sham groups (MSV and FSV),
castration greatly reduced the ACE activity of male rats
(MCV = 790 ± 58 AFU) but did not affect the ACE
activity of female rats (FCV = 1161 ± 39 AFU). When
compared to vehicle treatment, enalapril treatment
reduced the ACE activity in the non-castrated (MSE =
59 ± 20 AFU, FSE = 21 ± 4 AFU vs MSV and FSV,
respectively) and castrated (MCE = 8 ± 5 AFU, FCE =
32 ± 3 AFU vs MCV and FCV, respectively) rats of both
sexes (Figure 1).
Cytokines
IL-10. Figure 2A shows the sex differences in serum
IL-10 levels. The male sham vehicle group had a lower
IL-10 level than the female sham vehicle group (MSV =
12.8 ± 1.2 pg/mL vs FSV = 16.4 ± 1.1 pg/mL). In com-
Table 1. Effect of castration and/or enalapril treatment on body weight (BW), systolic blood pressure (SBP), serum testosterone and
estradiol, and uterine weight/body weight (UW/BW) ratio.
Group
(n = 7)
Initial BW
(g)
Final BW
(g)
Initial SBP
(mmHg)
Final SBP
(mmHg)
Serum testosterone
(ng/mL)
Serum estradiol
(ng/mL)
UW/BW
(mg/g)
MSV 232 ± 8* 278 ± 4*& 219 ± 5* 222 ± 5* 179 ± 14 – –
FSV 158 ± 4 187 ± 3& 177 ± 3 188 ± 4 25 ± 3 9.0 ± 0.15 1.43 ± 0.21
MCV 239 ± 6* 280 ± 6*& 223 ± 4* 221 ± 3* 15 ± 3+ – –
FCV 153 ± 3 217 ± 5+& 177 ± 2 192 ± 2 18 ± 2 6.5 ± 0.12+ 0.36 ± 0.05+
MSE 224 ± 5* 264 ± 7*& 215 ± 4* 153 ± 5+ 200 ± 20 – –
FSE 152 ± 5 183 ± 4& 181 ± 3 152 ± 4+ 28 ± 4 9.2 ± 0.10# 1.51 ± 0.21#
MCE 236 ± 3* 264 ± 5*& 222 ± 3* 148 ± 4+# 9.8 ± 2+ – –
FCE 157 ± 5 216 ± 3+& 175 ± 2 139 ± 3+# 19 ± 3 6.3 ± 0.31+ 0.32 ± 0.05+
Data are reported as means ± SE. M = male; F = female; SV = sham-operated vehicle; SE = sham-operated rats treated with
enalapril (10 mg?kg-1?day-1); CV = castrated + vehicle; CE = castrated and treated with enalapril. *P , 0.05 vs females of the same
group; +P , 0.05 vs sham vehicle animals of the same sex; #P , 0.05 vs castrated animals of the same sex; &P , 0.05 vs initial BW of
the same group (two-way ANOVA and Fisher test).
Figure 1. Plasma levels of angiotensin-converting exzyme (ACE)
activity (arbitrary fluorescence units, AFU) in SV (sham +
vehicle), SE (sham + enalapril), CV (castrated + vehicle), and
CE (castrated + enalapril) groups. Data are reported as means ±
SE. *P , 0.05 vs females of the same group; +P , 0.05 vs sham
vehicle animals of the same sex; #P , 0.05 vs castrated animals
of the same sex (two-way ANOVA and Fisher test).
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parison with the sham groups, orchiectomy increased
(MCV= 15.9 ± 2 pg/mL) and ovariectomy reduced (FCV
= 8.9 ± 0.9 pg/mL) IL-10 levels. When compared to the
vehicle treatment, enalapril treatment increased the
serum IL-10 concentrations in the male (MSE = 19.2 ±
3.1 pg/mL) and female (FSE = 23.5 ± 1.8 pg/mL) sham
groups. Enalapril treatment also increased the IL-10
levels of the castrated groups of male (MCE = 19.8 ±
0.7 pg/mL) and female (FCE = 20.1 ± 1.8 pg/mL) rats.
TNF-a. We observed different TNF-a concentrations
(Figure 2B) between the male (MSV = 12.8 ± 1 pg/mL)
and female sham vehicle groups (FSV = 16.6 ± 1.2 pg/
mL). Castration did not alter the TNF-a concentration in
males (MCV = 12.7 ± 1 pg/mL), but decreased it in
female rats (FCV = 10.9 ± 0.8 pg/mL) relative to the
sham vehicle group. Enalapril treatment did not change
the TNF-a concentration in males (MSE= 14.1 ± 0.5 pg/
mL), but it decreased the TNF-a concentration in the
female rats (FSE = 13 ± 1 pg/mL) relative to the sham
vehicle group. Treating castrated animals with enalapril
did not alter the concentration of TNF-a in males (MCE =
14.2 ± 1.2 pg/mL) or females (FCE= 12.7 ± 1.6 pg/mL)
relative to the CV groups, but it eliminated the sexual
dimorphism.
IL-6. The serum concentrations of IL-6 are shown in
Figure 2C. We observed sexual dimorphism in the IL-6
concentrations of the sham vehicle groups (MSV= 7.2 ±
0.2 pg/mL vs FSV = 10.3 ± 0.2 pg/mL). Castration
decreased the IL-6 concentrations in male (MCV = 4.2 ±
0.2 pg/mL) and female (FCV = 4.0 ± 0.6 pg/mL) rats
relative to the sham vehicle groups. Enalapril treatment
reduced IL-6 concentrations in the male (MSE = 3.2 ±
0.9 pg/mL) and female (FSE = 3.5 ± 0.2 pg/mL) sham
groups and eliminated the difference between sexes.
However, the association of enalapril treatment with
castration failed to change the IL-6 concentrations in
either the male (MCE= 5.9 ± 0.4 pg/mL) or female (FCE
= 5.5 ± 0.6 pg/mL) rats relative to the values obtained
for the respective CV groups.
Hormone levels and uterine weight
Castration resulted in significant reductions in the
levels of estradiol in female rats and in the levels of
testosterone in male rats. Enalapril treatment did not alter
the serum levels of estradiol or testosterone. As expected,
ovariectomy reduced the uterine weight/body weight ratio
(Table 1).
Discussion
It has been demonstrated that sex hormones and the
immune system are connected (4,8-10) and that differ-
ences in hormone levels between sexes can alter cytokine
production profiles (18). One of the main findings of the
present study was the observation of sex dimorphisms in
serum IL-10, TNF-a, and IL-6 levels in SHR. Furthermore,
data from clinical and experimental studies have empha-
sized the important roles of ACE inhibitors in affecting
non-hemodynamic, immune-mediated functions such as
cytokine production (19,20). In the present study, we
investigated the effect of the ACE inhibitor enalapril on
systemic cytokine production in SHR and showed that
enalapril increased the IL-10 levels and decreased the IL-
6 levels of both male and female hypertensive animals.
The data presented in this study demonstrated that
male SHR had a higher SBP than female SHR. Castration
did not alter this parameter and the differences in SBP
levels were maintained across the sexes. Female SHR
that were subjected to ovariectomy did not show changes
in their blood pressure (21,22). Previous studies have
shown that castration lowered the blood pressure of male
SHR rats (23-25); however, the initial blood pressure
detected in our animals was higher than in previous
studies, and the rats were castrated at a younger age (4
or 5 weeks) and observed for a longer period of time in our
study (23,25). However, it has not been clearly estab-
lished that the removal of sex hormones influences the
development of hypertension. Furthermore, SBP was
evaluated by direct measurements in anesthetized ani-
Figure 2. Cytokine levels. A, IL-10, B, TNF-a, and C, IL-6 levels of SV (sham + vehicle), SE (sham + enalapril), CV (castrated +
vehicle), and CE (castrated + enalapril) groups, as measured by ELISA. Data are reported as means± SE. *P, 0.05 vs females of the
same group; +P , 0.05 vs sham vehicle animals of the same sex; #P, 0.05 vs castrated animals of the same sex (two-way ANOVA
and Fisher test).
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mals (23-25).
Our results identified sexual dimorphisms in the levels
of the cytokines studied. Female SHR had higher levels of
both the pro- and anti-inflammatory cytokines than male
SHR. Establishing an estrogen-deficient state in female
rats by ovariectomy reduced the levels of all the cytokines
studied, whereas reducing the testosterone level in male
rats by orchiectomy resulted in a different cytokine profile.
Indeed, the effect of the female sex hormones appears to
be evident regarding cytokine levels; ovariectomy did not
change the ACE activity or the SBP but reduced all the
cytokines studied when compared to the sham vehicle
group. Orchiectomy decreased the ACE activity without
changing the SBP in male rats. On the other hand,
orchiectomy enhanced IL-10 and reduced IL-6 levels,
indicating a relationship between ACE activity and the
levels of these cytokines that was independent of the
SBP. Thus, in female rats the differences in the cytokine
levels between the sham and castrated animals are
influenced by the sex hormones independent of ACE
activity and SBP. However, in male rats the differences in
cytokine levels are influenced by ACE activity, which was
reduced after castration. These data suggest that sex
hormones influence the serum cytokine levels in SHR, but
generalizations cannot be made.
Estrogen appears to have a concentration-dependent
effect on immune response polarization as low levels of
exogenous estrogen were shown to support a proinflam-
matory Th1 (IL-1, IFN) response, while high doses of
estrogen support a Th2 response by upregulating the
production of IL-4, IL-10, and IL-6 (26,27). One of the
strengths of the present study was that the cytokine
measurements were carried out in sham females during
proestrus, the stage with the highest endogenous estro-
gen concentrations (27). This might be responsible for the
higher IL-10, IL-6, and TNF-a concentrations observed in
the female sham vehicle group because ovariectomy
decreased the cytokine concentrations.
Among the sham groups, male rats displayed lower IL-
10, IL-6, and TNF-a concentrations than female rats. A
direct relationship between testosterone and ACE activity
has been identified (28), and we demonstrated that
castration of male SHR reduced ACE activity. Therefore,
the increase in IL-10 levels and the decrease in IL-6 levels
observed after castration could have been due to ACE
inhibition. Castration or blockade of the testosterone
receptor with flutamide improved myocardial function
after acute ischemia-reperfusion by decreasing the levels
of proinflammatory cytokines (29). There are conflicting
reports in the literature regarding the relationship between
TNF-a and testosterone, with results showing both
increases (30) and decreases (8,29,30) in TNF-a levels
in the presence of testosterone.
We showed that male SHR had a higher serum ACE
activity than female SHR and that castration only affected
the ACE activity of male rats. Similarly, Pendergrass et al.
(12) showed that male hypertensive mRen(2).Lewis male
rats had a higher plasma ACE activity than females, and
Lim et al. (28) reported similar findings in mice. Another
study consistent with our results demonstrated that
normotensive female rats subjected to ovariectomy did
not show altered ACE activity (31). Other studies showed
that there were no changes in the pituitary (32) or
circulating (33) ACE activity levels during the normal
estrous cycle and that ACE activity was only reduced after
exogenous estrogen administration (32,33). This sug-
gested that ACE activity in plasma was only affected by
the administration of exogenous estrogen (31,33).
A sex difference in the bradykinin (BK) system has
been reported (34), and the level of BK may have
contributed to our results. Although the inhibition of ACE
determines the increase in BK levels (35), we cannot
assume an important role for the bradykinin system in our
results. Consistent with Reckelhoff et al. (21), we
demonstrated that there were no differences in blood
pressure levels between intact and ovariectomized
females. Therefore, because the decrease in blood
pressure after enalapril treatment was the same in the
ovariectomized and sham rats, despite the reduction in
the BK system in ovariectomized rats (36), it is debatable
whether the BK system played an important role in the
hypotensive effect of enalapril. Additionally, a study by
Majima et al. (37) found that the levels of BK needed to
reduce the blood pressure of SHR males were 20 to 100
times higher than the level produced by the ACE inhibitor
captopril. In another study, inhibition of BK with the BK
antagonist was shown to have no effect on the basal
blood pressure of SHR or WKY (38).
It is well established that Ang II may contribute
significantly to the development of diverse forms of
vascular disease by activating the components of the
inflammatory response (39) and that ACE inhibitors have
pleiotropic anti-inflammatory effects (13), most likely by
reducing activation of the nuclear factor-kappaB system
and reversing the elevated expression of proinflammatory
cytokines (5). We therefore used enalapril to assess the
influence of ACE on cytokine levels in both male and
female rats. First, we demonstrated that enalapril treat-
ment decreased both the blood pressure and ACE activity
of intact and castrated animals. Second, the pharmaco-
logical blockade of ACE led to changes in the cytokine
levels of the sham animals. The inhibition of ACE
decreased IL-6 and TNF-a levels and increased IL-10
levels in female rats and enhanced IL-10 levels, reduced
IL-6 levels, and did not change TNF-a levels in male rats.
However, castration increased IL-10 levels without affect-
ing the proinflammatory cytokine levels, despite reduc-
tions in the ACE activity and blood pressure compared to
the vehicle controls. Enalapril treatment markedly affected
the serum IL-10 levels in both castrated and non-
castrated hypertensive rats. It is known that endogenous
IL-10 limits Ang II-mediated increases in IL-6, oxidative
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stress, and vascular dysfunction (13). Therefore, enala-
pril-mediated increases in IL-10 and reductions in IL-6
may protect against Ang II-induced vascular dysfunction
and mediate vascular protection during hypertension and
other vascular diseases where Ang II plays a major role
(39).
The results presented in this report are consistent with
studies that demonstrated similar cytokine-modulating
effects of ACE inhibitors in various experimental models
(13,40). One could argue, however, that the effects of
enalapril treatment on the cytokine expression profiles
observed were due to a direct effect of blocking Ang II
activity or as a consequence of reduced hypertension.
Treatment with enalapril exerted important anti-inflamma-
tory activity in normotensive patients (13) and animals
(14). Based on our findings, the reduction in ACE activity
appears to influence the cytokine levels independently of
the reduction in blood pressure. For example, in the
castrated male rats, ACE activity is reduced without a
reduction in SBP, yet we observed an increase in IL-10
levels and a decrease in IL-6 levels, which shows that
testosterone influences the activity of ACE (27). Enalapril
treatment did not alter the proinflammatory cytokines in
either male or female castrated rats despite a decrease in
blood pressure. Therefore, enalapril treatment only
changes the proinflammatory cytokine profile in the
presence of the sex hormones, regardless of the
reduction in SBP.
This study identified sexual dimorphisms in serum
cytokine levels in SHR; sex hormones differentially
modulate levels of specific cytokines; male, but not
female, sex hormones modulate ACE activity; ACE
inhibition produces systemic anti-inflammatory and anti-
hypertensive effects in SHR regardless of sex. These
data support the evidence that both sex hormones and
the RAS affect cytokine expression profiles.
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